BAKER BROS ADVISORS LLC Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).

BAKER BROS ADVISORS LLC in BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 1,656,688 shares
Current Value: $9,393,421
Latest Transaction: Aug 16 2016
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in BIOCRYST PHARMACEUTICALS INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	4.29	850	3,645	9,418,390	9.4 M to 9.4 M (-0.01 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	4.29	140	600	1,551,387	1.6 M to 1.6 M (-0.01 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	4.83	343,583	1,658,681	9,419,240	9.8 M to 9.4 M (-3.52 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	4.83	56,417	272,359	1,551,527	1.6 M to 1.6 M (-3.51 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	5.25	296,856	1,559,711	9,762,823	10.1 M to 9.8 M (-2.95 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	5.25	48,744	256,106	1,607,944	1.7 M to 1.6 M (-2.94 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	5.00	2,834,561	14,172,805	10,059,679	12.9 M to 10.1 M (-21.98 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	5.00	465,439	2,327,195	1,656,688	2.1 M to 1.7 M (-21.93 %)
Feb 09 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.33	45,000	284,657	12,894,240	12.8 M to 12.9 M (+0.35 %)
Feb 04 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.65	24,800	164,915	12,849,240	12.8 M to 12.8 M (+0.19 %)
Feb 04 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.29	91,187	573,311	12,824,440	12.7 M to 12.8 M (+0.72 %)
Feb 04 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.52	91,728	598,360	12,733,253	12.6 M to 12.7 M (+0.73 %)
Jan 29 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.88	25,000	172,015	12,641,525	12.6 M to 12.6 M (+0.20 %)
Jan 29 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.98	63,345	441,971	12,616,525	12.6 M to 12.6 M (+0.50 %)
Jan 25 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.00	3,200	22,389	12,553,180	12.5 M to 12.6 M (+0.03 %)
Jan 25 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.29	103,600	755,368	12,549,980	12.4 M to 12.5 M (+0.83 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.94	1,325	9,197	12,446,380	12.4 M to 12.4 M (+0.01 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.87	51,370	352,974	12,445,055	12.4 M to 12.4 M (+0.41 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.12	92,200	656,750	12,393,685	12.3 M to 12.4 M (+0.75 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.49	25,000	187,333	12,301,485	12.3 M to 12.3 M (+0.20 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.45	175,000	1,303,890	12,276,485	12.1 M to 12.3 M (+1.45 %)

Page: 1